2022/07/06 News Release UBE Corporation to Begin Basic Design for DMC and EMC Plant Construction in the U.S.
2022/06/10 News Release Santen and UBE announces U.S. Food and Drug Administration accepts resubmission of NDA for STN1011700 / DE-117 (omidenepag isopropyl) for treating glaucoma and ocular hypertension
2022/04/28 News Release UBE Corporation Announces Change of Representative Director and Personnel Change
2022/04/12 News Release UBE Group Announces New Medium-Term Targets by 2030 for Achieving Carbon Neutrality by 2050
2022/04/07 News Release UBE Corporation Selected as a Constituent of FTSE Blossom Japan Sector Relative Index
2022/03/28 News Release Ube Industries and HiLung Sign Joint Development Agreement for Co-Development of Novel Selective LPA1 Antagonist HL001 for Pulmonary Fibrosis
2022/03/23 News Release Ube Industries and Kirilys Therapeutics, Inc. Sign License Agreement for CDK7 inhibitors
2022/02/28 News Release Shionogi and Ube Industries Enter into a Strategic Development Collaboration for the Novel Anti-RS Virus Drug Candidate S-337395
2021/12/24 News Release In antiplatelet agents Efient® Tablets 3.75 mg and Efient® Tablets 2.5 mg Supplemental New Drug Application Approval for Additional Indication, Dosage and Administration in Japan
2021/12/22 News Release (Revision of Disclosed Information) Ube Industries and Mitsubishi Materials Announce Change in the Amount of Capital and Timing of Name Change for Successor Company upon Company Split for Integration of Cement Businesses, etc.
2021/12/17 News Release Ube Industries Announces Absorption (Simplified Merger/Short-Form Merger) of Wholly-Owned Subsidiary Meiwa Plastic Industries, Ltd.